{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T09:10:53Z","timestamp":1759569053217,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2045,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01GN0945"],"award-info":[{"award-number":["01GN0945"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.exphem.2016.07.008","type":"journal-article","created":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T18:27:59Z","timestamp":1469644079000},"page":"1024-1033.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Longitudinal analyses of leukemia-associated antigen-specific CD8+ T\u00a0cells in patients after allogeneic stem cell transplantation"],"prefix":"10.1016","volume":"44","author":[{"given":"Elke","family":"R\u00fccker-Braun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia S.","family":"Link","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Schmiedgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Tunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Vizjak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Teipel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekka","family":"Wehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"K\u00fchn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yannik F.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uta","family":"Oelschl\u00e4gel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lothar","family":"Germeroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Schetelig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2016.07.008_bib1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bmt.1704953","article-title":"T-cell reconstitution and expansion after hematopoietic stem cell transplantation: \u2018T\u2019 it up!","volume":"35","author":"Porter","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.07.008_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2016.07.008_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/187152611794407764","article-title":"Challenges and advances in infection control of hematopoietic stem cell transplant recipients","volume":"11","author":"Magauran","year":"2011","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.exphem.2016.07.008_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri1526","article-title":"Cellular immunotherapy for viral infection after HSC transplantation","volume":"5","author":"Moss","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2016.07.008_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1074-7613(00)80028-X","article-title":"A new era for cancer immunotherapy based on the genes that encode cancer antigens","volume":"10","author":"Rosenberg","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2016.07.008_bib6","doi-asserted-by":"crossref","first-page":"174ra127","DOI":"10.1126\/scitranslmed.3004916","article-title":"Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients","volume":"5","author":"Chapuis","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2016.07.008_bib7","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1182\/blood.V100.10.3835","article-title":"Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL","volume":"100","author":"Bellantuono","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ijc.11200","article-title":"Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia","volume":"106","author":"Greiner","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2016.07.008_bib9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood-2011-11-394395","article-title":"Mutated regions of nucleophosmin 1 elicit both CD4(+) and CD8(+) T-cell responses in patients with acute myeloid leukemia","volume":"120","author":"Greiner","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14653240701218524","article-title":"Transfer of PR1-specific T-cell clones from donor to recipient by stem cell transplantation and association with GVL activity","volume":"9","author":"Rezvani","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.exphem.2016.07.008_bib11","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood.V90.7.2529","article-title":"Cytotoxic T lymphocytes specific for a nonpolymorphic proteinase 3 peptide preferentially inhibit chronic myeloid leukemia colony-forming units","volume":"90","author":"Molldrem","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0301-472X(02)00874-3","article-title":"Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia","volume":"30","author":"Greiner","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2016.07.008_bib13","doi-asserted-by":"crossref","first-page":"146463","DOI":"10.1155\/2012\/146463","article-title":"Immune responses to RHAMM in patients with acute myeloid leukemia after chemotherapy and allogeneic stem cell transplantation","volume":"2012","author":"Casalegno-Garduno","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.exphem.2016.07.008_bib14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood-2002-08-2554","article-title":"Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells","volume":"102","author":"Schmidt","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib15","first-page":"669","article-title":"Survivin\u2013a universal tumor antigen","volume":"17","author":"Andersen","year":"2002","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.exphem.2016.07.008_bib16","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1182\/blood-2004-07-2548","article-title":"Immunogenicity of Bcl-2 in patients with cancer","volume":"105","author":"Andersen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4161\/cbt.3.2.611","article-title":"Identification of novel survivin-derived CTL epitopes","volume":"3","author":"Reker","year":"2004","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.exphem.2016.07.008_bib18","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1182\/blood-2004-04-1233","article-title":"Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes","volume":"105","author":"Mayr","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib19","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.exphem.2010.07.002","article-title":"Streptamer-based selection of WT1-specific CD8+ T cells for specific donor lymphocyte infusions","volume":"38","author":"Wang","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2016.07.008_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.imbio.2013.10.008","article-title":"CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT","volume":"219","author":"Steger","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.exphem.2016.07.008_bib21","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2013-04-496844","article-title":"Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1mut)","volume":"122","author":"Greiner","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib22","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/leu.2010.29","article-title":"Peptide vaccination elicits leukemia-associated antigen-specific cytotoxic CD8+ T-cell responses in patients with chronic lymphocytic leukemia","volume":"24","author":"Giannopoulos","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2016.07.008_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1681\/ASN.2007111225","article-title":"Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes","volume":"20","author":"Babel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.exphem.2016.07.008_bib24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/S1521-6616(02)00019-0","article-title":"Diagnostic potential of tetramer-based monitoring of cytomegalovirus-specific CD8+ T lymphocytes in allogeneic stem cell transplantation","volume":"106","author":"Gratama","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.exphem.2016.07.008_bib25","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1182\/blood.V97.5.1232","article-title":"Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation","volume":"97","author":"Cwynarski","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2013.11.007","article-title":"Multimer monitoring of CMV-specific T cells in research and in clinical applications","volume":"78","author":"Borchers","year":"2014","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.exphem.2016.07.008_bib27","doi-asserted-by":"crossref","first-page":"e50248","DOI":"10.1371\/journal.pone.0050248","article-title":"Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation","volume":"7","author":"Borchers","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2016.07.008_bib28","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jcyt.2014.05.023","article-title":"Clinical-scale isolation of \u2018minimally manipulated\u2019 cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease","volume":"16","author":"Odendahl","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.exphem.2016.07.008_bib29","first-page":"3390","article-title":"CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope","volume":"118","author":"Skowera","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2016.07.008_bib30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/leu.2014.233","article-title":"Mapping the HLA ligandome landscape of acute myeloid leukemia: a targeted approach toward peptide-based immunotherapy","volume":"29","author":"Berlin","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2016.07.008_bib31","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/blood.V89.4.1405","article-title":"Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia","volume":"89","author":"Inoue","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3324\/haematol.2013.093690","article-title":"A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells","volume":"99","author":"van Loenen","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2016.07.008_bib33","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1182\/blood-2007-03-076844","article-title":"Graft-versus-leukemia effects associated with detectable Wilms tumor-1 specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia","volume":"110","author":"Rezvani","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib34","doi-asserted-by":"crossref","first-page":"e41648","DOI":"10.1371\/journal.pone.0041648","article-title":"Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Lilleri","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2016.07.008_bib35","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1182\/blood-2003-01-0150","article-title":"Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation","volume":"102","author":"Rezvani","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib36","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2002-01-0163","article-title":"CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia","volume":"100","author":"Scheibenbogen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib37","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.humimm.2009.08.006","article-title":"Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning","volume":"70","author":"Schmidt","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.exphem.2016.07.008_bib38","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1182\/blood-2012-03-417972","article-title":"Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5\/5q","volume":"120","author":"Middeke","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib39","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2013-12-544957","article-title":"Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation","volume":"123","author":"Middeke","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib40","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1200\/JCO.2007.15.4757","article-title":"Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning","volume":"26","author":"Sorror","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2016.07.008_bib41","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1182\/blood-2010-03-275420","article-title":"Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial","volume":"116","author":"Dreger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.07.008_bib42","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nm.3100","article-title":"Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation","volume":"19","author":"van Heijst","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2016.07.008_bib43","doi-asserted-by":"crossref","first-page":"128ra142","DOI":"10.1126\/scitranslmed.3003647","article-title":"T cell receptor alphabeta diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection","volume":"4","author":"Wang","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2016.07.008_bib44","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/bmt.2015.133","article-title":"Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients","volume":"50","author":"Yew","year":"2015","journal-title":"Bone Marrow Transplant"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X16305100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X16305100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:32:44Z","timestamp":1759566764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X16305100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0301472X16305100"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2016.07.008","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal analyses of leukemia-associated antigen-specific CD8+ T\u00a0cells in patients after allogeneic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2016.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}